Skip to content
Menu

WBB Securities Upgrades Turn Therapeutics to Hold, Maintains Price Target to $10

Benzinga Newsdesk 4 weeks ago

Analyst RatingsNewsUpgradesPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

WBB Securities analyst Karen Sterling upgrades Turn Therapeutics (NASDAQ:TTRX) from Sell to Hold and maintains the price target from $10 to $10.

WBB Securities analyst Karen Sterling upgrades Turn Therapeutics (NASDAQ:TTRX) from Sell to Hold and maintains the price target from $10 to $10.

Read at benzinga.com

← All stock news